Power Law company profile

NBE-Therapeutics

Biotech & Life Sciences · Basel, Switzerland · Founded 2012 Unicorn

Focused on developing next-generation antibody-drug conjugates for cancer treatment

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$1–10M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

4 investors on NBE-Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Boehringer Ingelheim Venture Fund

Series B+ 3 investors entered at this stage

Boehringer Ingelheim

PPF Group

Novo Holdings

Global footprint

Where NBE-Therapeutics has talent and traffic

Workforce by country

4 countries with
team presence

🇨🇭 Switzerland78.6%

🇩🇪 Germany13.1%

🇫🇷 France5.5%

🇺🇸 United States2.9%

4 countries shown

Web traffic by country

3.7K monthly visits
across markets

🇨🇭 Switzerland78.4%

🇬🇧 United Kingdom13.5%

🇩🇪 Germany8.1%

Top 3 markets shown

Patent intelligence

$29M patent portfolio · 14 active families

Estimated portfolio value

$29M

2.2% of valuation · 27× smaller than top peer BioNTech ($780M)

14 active patent families

Where NBE-Therapeutics innovates Molecular biologyBinding proteinPharmaceutical drugEnzymeAntigen binding

Where NBE-Therapeutics concentrates vs peers

Each axis is a top-10 topic across NBE-Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about NBE-Therapeutics

An AI-synthesized read of the highest-engagement posts about NBE-Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NBE-Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles